TYROSINE KINASE INHIBITOR COMBINATIONS AND THEIR USE
摘要
The invention relates to pharmaceutical combination product comprising (i) a MET inhibitor and (ii) an FGFR inhibitor, or a pharmaceutically acceptable salt thereof, respectively, or a prodrug thereof, respectively, and at least one pharmaceutically acceptable carrier.
申请公布号
WO2013151913(A1)
申请公布日期
2013.10.10
申请号
WO2013US34759
申请日期
2013.04.01
申请人
NOVARTIS AG;TIEDT, RALPH;BUCKLER, ALAN;HARBINSKI, FRED;SANGHAVI, SNEHA;JEFFERY, DOUGLAS;WILSON, CHRISTOPHER
发明人
TIEDT, RALPH;BUCKLER, ALAN;HARBINSKI, FRED;SANGHAVI, SNEHA;JEFFERY, DOUGLAS;WILSON, CHRISTOPHER